$16.35
-0.14-0.85%
At close: -
$16.35
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Avantor Insider Trading Activity | NYSE:AVTR | Benzinga
Track the latest Avantor insider trading activity. Stay informed on recent buys, sells, and market impact for Avantor stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Avantor Inc Insiders Doing?
At Avantor Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 10.47K shares worth $182.62K, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
- On February 28, 2025, James Bramwell, the company's EVP SALES, CUSTOMER EXCELLENCE sold 4.53K shares for $17.44 each.
- On February 28, 2025, Steven Eck, the company's SVP & CHIEF ACCOUNTING OFFICER sold 5.94K shares for $17.44 each.
Ownership Statistics for Avantor Inc
Shares Outstanding
680.903M
Insider Shares Owned
4.809M
Insider Percentage Owned
0.71%
Institutional Shares Held
554.773M
Institutional Percentage Held
81.5%
| Feb 28, 2025 | James Bramwell | EVP SALES, CUSTOMER EXCELLENCE | -4.53K | $17.44 | -$79.04K | SELL | -4.97% | 86.61K | Feb 26 - Feb 27 | View |
| Feb 28, 2025 | Steven Eck | SVP & CHIEF ACCOUNTING OFFICER | -5.94K | $17.44 | -$103.58K | SELL | -13.05% | 39.57K | Feb 26 - Feb 27 | View |
| Sep 06, 2024 | Steven Eck | SVP & CHIEF ACCOUNTING OFFICER | -3.52K | $25.06 | -$88.34K | SELL | -10.66% | 29.54K | Sep 05 | View |
| Aug 01, 2024 | Christophe Couturier | EVP, AMEA | -10.10K | $27.01 | -$272.80K | SELL | -12.02% | 73.93K | Jul 30 - Jul 31 | View |
| Mar 12, 2024 | Steven Eck | SVP & CHIEF ACCOUNTING OFFICER | -3.69K | $25.63 | -$94.45K | SELL | -9.67% | 34.41K | Mar 08 | View |
| Mar 01, 2024 | James Bramwell | EVP SALES, CUSTOMER EXCELLENCE | -4.91K | $24.52 | -$120.39K | SELL | -4.85% | 96.23K | Feb 29 | View |
| Mar 01, 2024 | Christophe Couturier | EVP, AMEA | -13.07K | $24.53 | -$320.71K | SELL | -13.48% | 83.89K | Feb 29 | View |
| Feb 27, 2024 | James Bramwell | EVP SALES, CUSTOMER EXCELLENCE | 14.33K | $24.49 | -$151.91K | GRANT | 16.51% | 101.14K | Feb 23 - Feb 27 | View |
| Sep 07, 2023 | Steven Eck | SVP & CHIEF ACCOUNTING OFFICER | -7.58K | $20.64 | -$156.39K | SELL | -21.19% | 28.19K | Sep 07 | View |
| Aug 28, 2023 | Frederic Vanderhaegen | EVP, AMERICAS AND EUROPE | -25.00K | $21.47 | -$536.75K | SELL | -13.46% | 160.74K | Aug 25 | View |
| Apr 13, 2023 | Christophe Couturier | EVP, AMEA | -1.50K | $21.18 | -$31.73K | SELL | -1.50% | 98.65K | Apr 11 | View |
| Mar 06, 2023 | Gerard Brophy | EVP, BIOPHARMA PRODUCTION | -3.91K | $25.00 | -$97.85K | SELL | -3.48% | 108.72K | Mar 03 | View |
| Mar 01, 2023 | Gerard Brophy | EVP, BIOPHARMA PRODUCTION | -3.06K | $25.00 | -$76.47K | SELL | -2.64% | 112.63K | Feb 27 | View |
| Mar 01, 2023 | Christophe Couturier | EVP, AMEA | -2.32K | $24.32 | -$56.52K | SELL | -2.26% | 100.72K | Feb 28 | View |
| Feb 27, 2023 | Christophe Couturier | EVP, AMEA | 5.18K | $24.32 | -$96.34K | GRANT | 5.29% | 103.04K | Feb 23 - Feb 25 | View |
| Feb 22, 2023 | Christophe Couturier | EVP, AMEA | -20.33K | $24.14 | -$490.78K | SELL | -17.30% | 97.16K | Feb 20 - Feb 22 | View |
| Feb 02, 2023 | Gerard Brophy | EVP, BIOPHARMA PRODUCTION | 12.18K | $24.40 | -$647.94K | GRANT | 13.50% | 102.39K | Jan 31 - Feb 02 | View |
| Nov 17, 2022 | Thomas Szlosek | EVP & CFO | 12.50K | $20.71 | $258.85K | BUY | 8.87% | 153.38K | Nov 16 | View |
| Nov 17, 2022 | Michael Stubblefield | CEO | 15.00K | $20.95 | $314.25K | BUY | 0.93% | 1.62M | Nov 16 | View |
| May 23, 2022 | Gerard Brophy | EVP, BIOPHARMA PRODUCTION | -19.60K | $31.27 | -$612.99K | SELL | -16.82% | 96.94K | May 20 | View |
| May 23, 2022 | Frederic Vanderhaegen | EVP, AMERICAS & EUROPE | -39.00K | $31.61 | -$1.23M | SELL | -23.53% | 126.76K | May 23 | View |
| Mar 02, 2022 | Gerard Brophy | EVP, BIOPHARMA PRODUCTION | -2.03K | $34.47 | -$69.87K | SELL | -1.47% | 136.22K | Mar 01 | View |
| Feb 25, 2022 | Gerard Brophy | EVP, BIOPHARMA PRODUCTION | 10.01K | $34.43 | -$175.67K | GRANT | 7.80% | 138.25K | Feb 23 - Feb 25 | View |
| Jan 05, 2022 | Gerard Brophy | EVP, BIOPHARMA PRODUCTION | -18.07K | $29.51 | -$2.05M | SELL | -12.09% | 131.31K | Jan 02 - Jan 05 | View |
| Dec 28, 2021 | Christophe Couturier | EVP, AMEA | 0.00 | $32.42 | -$187.59K | SELL-OPTIONS | 0.00% | 110.50K | Dec 27 | View |
| Dec 23, 2021 | Christophe Couturier | EVP, AMEA | 0.00 | $32.22 | -$1.20M | SELL-OPTIONS | 0.00% | 110.50K | Dec 21 - Dec 22 | View |
| Dec 10, 2021 | Christophe Couturier | EVP, AMEA | 0.00 | $28.90 | -$307.52K | SELL-OPTIONS | 0.00% | 110.50K | Dec 08 - Dec 09 | View |
| Dec 03, 2021 | RAJIV GUPTA | DIRECTOR | -100.00K | $39.30 | -$3.93M | SELL | -10.21% | 879.35K | Dec 01 | View |
| Nov 15, 2021 | Frederic Vanderhaegen | EVP, EUROPE | -60.80K | $30.76 | -$3.54M | SELL | -28.24% | 154.50K | Nov 11 - Nov 12 | View |
| Nov 02, 2021 | RAJIV GUPTA | DIRECTOR | -100.00K | $40.31 | -$4.03M | SELL | -9.26% | 979.35K | Nov 01 | View |
| Oct 04, 2021 | RAJIV GUPTA | DIRECTOR | -100.00K | $39.94 | -$3.99M | SELL | -8.48% | 1.08M | Oct 01 | View |
| Sep 22, 2021 | Michael Stubblefield | PRESIDENT AND CEO | -141.30K | $42.37 | -$5.99M | SELL | -10.07% | 1.26M | Sep 20 | View |
| Sep 02, 2021 | RAJIV GUPTA | DIRECTOR | -100.00K | $39.45 | -$3.95M | SELL | -7.82% | 1.18M | Sep 01 | View |
| Aug 27, 2021 | Steven Eck | SVP & CHIEF ACCOUNTING OFFICER | -17.38K | $40.08 | -$696.71K | SELL | -55.13% | 14.15K | Aug 26 | View |
| Aug 23, 2021 | RAJIV GUPTA | DIRECTOR | -100.00K | $38.81 | -$3.88M | SELL | -7.25% | 1.28M | Aug 20 | View |
| Aug 13, 2021 | Jo Natauri | DIRECTOR | 300.00 | $36.33 | $10.90K | BUY | 0.05% | 650.32K | Jul 12 | View |
| Aug 02, 2021 | Gerard Brophy | EVP, BIOPHARMA PRODUCTION | 0.00 | $30.22 | -$1.14M | SELL-OPTIONS | 0.00% | 149.38K | Jul 30 | View |
| Jul 21, 2021 | James Bramwell | EVP, STRATEGIC PARTNERS | -6.11K | $37.00 | -$226.14K | SELL | -7.11% | 79.90K | Jul 20 | View |
| Jul 13, 2021 | James Bramwell | EVP, STRATEGIC PARTNERS | -18.33K | $35.61 | -$652.83K | SELL | -17.57% | 86.01K | Jul 09 | View |
| Jun 29, 2021 | Christophe Couturier | EVP, AMEA | -28.10K | $35.73 | -$1.00M | SELL | -20.33% | 110.08K | Jun 28 | View |
| Jun 28, 2021 | RAJIV GUPTA | DIRECTOR | -68.61K | $35.32 | -$2.42M | SELL | -4.74% | 1.38M | Jun 25 | View |
| Jun 10, 2021 | Michael Stubblefield | PRESIDENT AND CEO | 0.00 | $17.69 | -$14.08M | SELL-OPTIONS | 0.00% | 1.40M | Jun 08 - Jun 10 | View |
| May 28, 2021 | RAJIV GUPTA | DIRECTOR | -228.11K | $31.91 | -$7.28M | SELL | -11.67% | 1.73M | May 26 - May 27 | View |
| May 28, 2021 | Devashish Ohri | EVP, IMEA | 0.00 | $27.60 | -$878.00K | SELL-OPTIONS | 0.00% | 139.09K | May 27 | View |
| May 27, 2021 | Devashish Ohri | EVP, IMEA | 0.00 | $27.54 | -$129.90K | SELL-OPTIONS | 0.00% | 139.09K | May 26 | View |
| May 26, 2021 | RAJIV GUPTA | DIRECTOR | -337.57K | $31.66 | -$10.69M | SELL | -14.73% | 1.95M | May 24 | View |
| May 25, 2021 | Devashish Ohri | EVP, IMEA | 0.00 | $24.71 | -$128.47K | SELL-OPTIONS | 0.00% | 139.09K | May 24 | View |
| May 24, 2021 | Michael Wondrasch | EVP & CIO | -18.49K | $31.41 | -$580.71K | SELL | -14.03% | 113.30K | May 21 | View |
| May 21, 2021 | Justin Miller | EVP & GENERAL COUNSEL | -18.49K | $31.12 | -$575.35K | SELL | -17.60% | 86.54K | May 20 | View |
| May 21, 2021 | Christophe Couturier | EVP, AMEA | -25.01K | $31.13 | -$778.56K | SELL | -15.33% | 138.17K | May 20 | View |
| May 21, 2021 | Gerard Brophy | EVP, BIOPHARMA PRODUCTION | -19.60K | $31.10 | -$609.65K | SELL | -11.60% | 149.38K | May 20 | View |
| May 13, 2021 | Jo Natauri | DIRECTOR | -27.26M | $30.85 | -$840.88M | SELL | -99.66% | 92.66K | May 11 | View |
| May 07, 2021 | Jo Natauri | DIRECTOR | -950.00 | $16.33 | -$13.30K | SELL | -0.00% | 72.62M | May 17 - Sep 25 | View |
| May 07, 2021 | GOLDMAN SACHS CO LLCStoneBridge LPStoneBridge Offshore LPVWR Partners LPBroad Street Principal Investments LLCBridge Street Opportunity Advisors LLCGOLDMAN SACHS GROUP INCStoneBridge LPStoneBridge Offshore LP | 10% OWNER | -950.00 | $16.33 | -$13.30K | SELL | -0.00% | 72.62M | May 17 - Sep 25 | View |
| May 07, 2021 | Thomas Connolly | DIRECTOR | -950.00 | $16.33 | -$13.30K | SELL | -0.00% | 72.62M | May 17 - Sep 25 | View |
| May 04, 2021 | Devashish Ohri | EVP, IMEA | 0.00 | $27.89 | -$502.69K | SELL-OPTIONS | 0.00% | 155.89K | Apr 30 | View |
| Apr 13, 2021 | Devashish Ohri | EVP, IMEA | 0.00 | $16.98 | -$3.08M | SELL-OPTIONS | 0.00% | 155.89K | Apr 12 | View |
| Apr 13, 2021 | Frederic Vanderhaegen | EVP, EUROPE | -27.07K | $31.80 | -$861.00K | SELL | -11.11% | 216.59K | Apr 12 | View |
| Apr 13, 2021 | James Bramwell | EVP, STRATEGIC PARTNERS | -2.50K | $32.00 | -$80.16K | SELL | -2.08% | 118.14K | Apr 12 | View |
| Apr 13, 2021 | Justin Miller | EVP & GENERAL COUNSEL | -2.90K | $28.19 | -$1.09M | SELL | -2.38% | 118.68K | Apr 12 | View |
| Mar 10, 2021 | Frederic Vanderhaegen | EVP, EUROPE | -10.00K | $28.21 | -$282.10K | SELL | -3.94% | 243.67K | Mar 09 | View |
| Mar 03, 2021 | Michael Wondrasch | EVP & CIO | -3.04K | $28.71 | -$87.16K | SELL | -2.04% | 145.44K | Mar 02 | View |
| Feb 26, 2021 | Gerard Brophy | EVP, BIOPHARMA PRODUCTION | -3.06K | $27.93 | -$85.44K | SELL | -1.74% | 172.38K | Feb 24 | View |
| Feb 23, 2021 | Gerard Brophy | EVP, BIOPHARMA PRODUCTION | -3.07K | $23.15 | -$304.61K | SELL | -1.72% | 175.44K | Feb 22 | View |
| Feb 08, 2021 | Michael Wondrasch | EVP & CIO | -9.47K | $26.48 | -$544.66K | SELL | -6.27% | 141.54K | Feb 05 | View |
| Jan 13, 2021 | James Bramwell | EVP, STRATEGIC PARTNERS | -2.50K | $30.00 | -$75.15K | SELL | -2.11% | 116.43K | Jan 11 | View |
| Jan 13, 2021 | Gerard Brophy | EVP, BIOPHARMA PRODUCTION | 0.00 | $26.63 | -$2.60M | SELL-OPTIONS | 0.00% | 178.51K | Jan 11 | View |
| Jan 08, 2021 | Gerard Brophy | EVP, BIOPHARMA PRODUCTION | -11.51K | $27.24 | -$313.51K | SELL | -6.06% | 178.51K | Jan 06 | View |
| Jan 06, 2021 | Gerard Brophy | EVP, BIOPHARMA PRODUCTION | -6.56K | $23.16 | -$742.57K | SELL | -3.34% | 190.02K | Jan 02 - Jan 04 | View |
| Dec 23, 2020 | James Bramwell | — | -10.02K | $27.14 | -$271.94K | SELL | -7.84% | 117.77K | Dec 21 | View |
| Dec 15, 2020 | Christi Shaw | — | -14.29K | $26.68 | -$381.15K | SELL | -55.79% | 11.32K | Dec 11 | View |
| Dec 08, 2020 | Michael Stubblefield | — | 580.33K | $14.38 | -$12.12M | OPTION EXERCISE | 45.81% | 1.85M | Dec 04 - Dec 07 | View |
| Nov 10, 2020 | New Mountain Investments III LLCNew Mountain Partners III LPNew Mountain Capital LLCNew Mountain Capital Group LPNM Holdings GP LLCSTEVEN KLINSKY | — | -36.02M | $24.81 | -$893.49M | SELL | -56.26% | 28.00M | Nov 10 | View |
| Oct 07, 2020 | Devashish Ohri | — | 0.00 | $12.51 | -$2.26M | OPTION EXERCISE | 0.00% | 151.67K | Oct 05 | View |
| Sep 17, 2020 | Devashish Ohri | — | 0.00 | $12.31 | -$749.70K | OPTION EXERCISE | 0.00% | 151.67K | Sep 16 | View |
| Sep 09, 2020 | Justin Miller | — | -22.89K | $21.17 | -$484.52K | SELL | -16.78% | 113.51K | Sep 08 | View |
| Aug 25, 2020 | Jo Natauri | — | -15.40M | $19.51 | -$300.34M | SELL | -26.15% | 43.48M | Aug 21 | View |
| Aug 25, 2020 | GOLDMAN SACHS CO LLCStoneBridge LPStoneBridge Offshore LPVWR Partners LPBroad Street Principal Investments LLCBridge Street Opportunity Advisors LLCGOLDMAN SACHS GROUP INCStoneBridge Offshore LPStoneBridge LP | — | -15.40M | $19.51 | -$300.34M | SELL | -26.15% | 43.48M | Aug 21 | View |
| Aug 25, 2020 | New Mountain Investments III LLCNew Mountain Partners III LPNew Mountain Capital LLCNew Mountain Capital Group LPNM Holdings GP LLCSTEVEN KLINSKY | — | -25.58M | $19.51 | -$498.89M | SELL | -28.55% | 64.02M | Aug 21 | View |
| Aug 03, 2020 | Devashish Ohri | — | 0.00 | $11.49 | -$691.95K | OPTION EXERCISE | 0.00% | 151.67K | Jul 30 | View |
| Jun 02, 2020 | Devashish Ohri | — | 0.00 | $10.22 | -$1.12M | OPTION EXERCISE | 0.00% | 151.67K | May 29 | View |
| May 28, 2020 | New Mountain Investments III LLCNew Mountain Partners III LPNew Mountain Capital LLCNew Mountain Capital Group LPNM Holdings GP LLCSTEVEN KLINSKY | — | -20.89M | $15.90 | -$332.19M | SELL | -18.91% | 89.59M | May 26 | View |
| May 28, 2020 | Jo Natauri | — | -12.59M | $7.95 | -$218.25M | SELL | -17.62% | 58.88M | Jun 13 - May 26 | View |
| May 28, 2020 | Thomas Connolly | — | -12.59M | $7.95 | -$218.25M | SELL | -17.62% | 58.88M | Jun 13 - May 26 | View |
| May 28, 2020 | GOLDMAN SACHS CO LLCStoneBridge LPStoneBridge Offshore LPVWR Partners LPBroad Street Principal Investments LLCBridge Street Opportunity Advisors LLCGOLDMAN SACHS GROUP INCStoneBridge LPStoneBridge Offshore LP | — | -12.59M | $7.95 | -$218.25M | SELL | -17.62% | 58.88M | Jun 13 - May 26 | View |
| May 27, 2020 | Michael Wondrasch | — | -22.99K | $17.82 | -$409.63K | SELL | -12.98% | 154.09K | May 22 | View |
| May 22, 2020 | Gerard Brophy | — | -25.50K | $17.36 | -$442.59K | SELL | -11.48% | 196.58K | May 20 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.